Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;49(3):539-556.
doi: 10.1016/j.gtc.2020.04.008. Epub 2020 Jun 20.

Endoscopic and Surgical Treatments for Gastroparesis: What to Do and Whom to Treat?

Affiliations
Review

Endoscopic and Surgical Treatments for Gastroparesis: What to Do and Whom to Treat?

Roman V Petrov et al. Gastroenterol Clin North Am. 2020 Sep.

Abstract

Gastroparesis is a complex chronic debilitating condition of gastric motility resulting in the delayed gastric emptying and multiple severe symptoms, which may lead to malnutrition and dehydration. Initial management of patients with gastroparesis focuses on the diet, lifestyle modification and medical therapy. Various endoscopic and surgical interventions are reserved for refractory cases of gastroparesis, not responding to conservative therapy. Pyloric interventions, enteral access tubes, gastric electrical stimulator and gastrectomy have been described in the care of patients with gastroparesis. In this article, the authors review current management, indications, and contraindications to these procedures.

Keywords: Gastric electrical stimulator; Gastric pacemaker; Gastric peroral endoscopic myotomy (GPOEM); Gastroparesis; Peroral pyloromyotomy (POP); Pyloromyotomy; Pyloroplasty.

PubMed Disclaimer

Conflict of interest statement

Disclosure Funded by: NIHHYB. Grant number(s): NIH/NCI Cancer Center Support Grant P30 CA006927. NIHMS-ID: 1591505.

Figures

Figures 1
Figures 1
Steps of the GPOEM procedure. A. Initial mucosal entry – 5 cm proximal to the pylorus on the greater curvature. B. Dissection of the submucosal entry. C. Myotomy. D. Closure of the mucosotomy with the Overstitch device.
Figure 2
Figure 2
Surgical pyloroplasty procedure. A. Placement of the incisions across the pylorus. B. Approximation of the defect in the transverse fashion. C. Heineke Mikulicz closure of the pyloroplasty incision. D. Reinforcement of the closure with omental flap.
Figure 3
Figure 3
Gastric electric stimulator implantation procedure. A. Placement of the stimulator in the subcutaneous pocket in the left subcostal area. B. Intramural placement of the electrodes with direct visual control with intraoperative endoscopy.
Figure 4
Figure 4
Complication of jejunostomy tubes. A. Early postoperative migration of the balloon into the abdominal wall with the leak and necrotizing fasciitis of the abdominal wall. B. Late postoperative erosion of the balloon through the abdominal wall resulting in the leak and dermatitis.
Figure 5
Figure 5
Different location of the device in the abdominal wall. A. Right lower quadrant location with long intraabdominal course of the leads. B. Left subcostal area location with very short intraabdominal length of the wires with the majority coiled over the fascia under the device. From Frontline Medical Communications Inc., publisher of the Journal of Clinical Outcomes Management; 2019; 26(1):31-32; with permission.
Figure 6
Figure 6
Complications of the gastric electric stimulator. A. Erosion of the device through the skin. B. Postoperative hematoma. C. Specimen of resected segment of the gastric wall due to erosion of the GES leads component (please note silicone retention disk protruding though the mucosa). From Frontline Medical Communications Inc., publisher of the Journal of Clinical Outcomes Management; 2019; 26(1):31-32; with permission.
Figure 7
Figure 7
Twiddler syndrome. A. Postoperative image after implantation of the GES. B. Image of the same patient 11 month postoperatively. Patient returned with recurrence of symptoms and image reveals flipped device with braded leads.
Figure 8
Figure 8
TYRX Antibiotic envelope for the cardiac stimulator.
Figure 9
Figure 9
Bowel obstruction due to stimulator leads. A. Preoperative scout image revealing high grade bowel obstruction and stimulator leads. B. Intraoperative image of the same patient, demonstrating loops of bowels wrapped around the leads. Leads were preserved. C. Postoperative image of another patient after laparotomy for bowel obstruction where leads were sacrificed. From Frontline Medical Communications Inc., publisher of the Journal of Clinical Outcomes Management; 2019; 26(1):31-32; with permission.
Figure 10
Figure 10
Placement of gastric stimulator leads. A. Fixation of the leads in the muscular layer of the gastric wall. B. Omental flap coverage of the implanted leads.
Figure 11
Figure 11
Abdominal imaging in the investigation of patients with recurrence of symptoms and abnormal Impedance values. A. Fracture of the lead along the medial border of the device. B. Migration of the lead. Please note wide spaced distance between the leads and lack of association of the medial lead with retention clips. From Frontline Medical Communications Inc., publisher of the Journal of Clinical Outcomes Management; 2019; 26(1):31-32; with permission.
Figure 12
Figure 12
Decision algorithm for the choice of procedure in patients with gastroparesis.

References

    1. Soykan I, Sivri B, Sarosiek I, Kiernan B, McCallum RW. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998. November;43(11):2398–404. - PubMed
    1. Rabine JC, Barnett JL. Management of the patient with gastroparesis. J Clin Gastroenterol. 2001. January;32(1):11–8. - PubMed
    1. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med. 1995. March 23;332(12):774–8. - PubMed
    1. Miller LS, Szych GA, Kantor SB, Bromer MQ, Knight LC, Maurer AH, et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol. 2002. July;97(7):1653–60. - PubMed
    1. Lacy BE, Crowell MD, Schettler-Duncan A, Mathis C, Pasricha PJ. The treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care. 2004. October;27(10):2341–7. - PubMed

Publication types

Substances